Speaker illustration

Doctor Mansoor Husain

University of Toronto, Toronto (Canada)

Dr. Mansoor Husain is Executive Director of the Ted Rogers Centre for Heart Research and Professor of Medicine at University of Toronto. He is an Attending Staff Cardiologist at the University Health Network where he works in the cardiac intensive care unit, nuclear cardiology, and ambulatory cardiology. Dr. Husain was the gold medallist in Medicine at University of Alberta, completed his clinical training at University of Toronto, and undertook post-doctoral training in the Program of Excellence in Cardiovascular Biology at Massachusetts Institute of Technology. His research aims to elucidate the molecular bases of cardiovascular diseases such as hypertension, atherosclerosis and heart failure, with a particular emphasis on identifying therapeutic targets involved in pathophysiology. Dr. Husain’s bench-to-bedside work has improved our understanding of the cardiovascular mechanisms of glucagon-like peptide-1 and related anti-diabetic drugs.

Cardiovascular effects of glucagon-like peptide 1 receptor agonists.

Event: ESC Congress 2021 - The Digital Experience

Topic: Risk Factors and Prevention

Session: Exploring the latest evidence of cardiovascular benefits with glucagon-like peptide 1 receptor agonists

Thumbnail

GLP-1 and the cardiovascular system

Event: ESC Congress 2019

Topic: Diabetes and the Heart

Session: GLP-1 Receptor agonists – Pioneers of further cardiovascular risk reduction in diabetes?

Thumbnail

Arrythmias and heart rate increase in the LEADER trial and relation to risk of cardiovascular events

Event: ESC Congress 2018

Topic: Pharmacotherapy

Session: Diabetes, adiposity and metabolic syndrome

Thumbnail

Connect with the speakers: questions & answers.

Event: ESC Congress 2018

Topic: Diabetes and the Heart

Session: Joining clinical practices: cardiovascular disease and type 2 diabetes

Thumbnail

Aligning treatment barriers with practical considerations.

Event: ESC Congress 2018

Topic: Diabetes and the Heart

Session: Joining clinical practices: cardiovascular disease and type 2 diabetes

Thumbnail

Interactive discussions - GLP-1 receptor agonists and CV risk management in type 2 diabetes: a new treatment paradigm?

Event: ESC Congress 2017

Topic: Diabetes, dysglycaemia and metabolic syndrome

Session: GLP-1 receptor agonists and cardiovascular risk management in type 2 diabetes: a new treatment paradigm?

Thumbnail

Results from the LEADER cardiovascular outcomes trial.

Event: ESC Congress 2017

Topic: Diabetes, dysglycaemia and metabolic syndrome

Session: GLP-1 receptor agonists and cardiovascular risk management in type 2 diabetes: a new treatment paradigm?

Thumbnail

Cardiovascular outcomes trials in diabetes – What have we learned?

Event: ESC Congress 2016

Topic: Diabetes management

Session: Addressing cardiovascular risk in type 2 diabetes - The LEADER trial

Thumbnail